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Abstract
In this work we present a novel system for generation of virtual PET images using CT scans. We combine a fully convolutional
network (FCN) with a conditional generative adversarial network (GAN) to generate simulated PET data from given input CT
data. The synthesized PET can be used for false-positive reduction in lesion detection solutions. Clinically, such solutions may
enable lesion detection and drug treatment evaluation in a CT-only environment, thus reducing the need for the more expensive
and radioactive PET/CT scan. Our dataset includes 60 PET/CT scans from Sheba Medical center. We used 23 scans for training
and 37 for testing. Different schemes to achieve the synthesized output were qualitatively compared. Quantitative evaluation was
conducted using an existing lesion detection software, combining the synthesized PET as a false positive reduction layer for the
detection of malignant lesions in the liver. Current results look promising showing a 28% reduction in the average false positive
per case from 2.9 to 2.1. The suggested solution is comprehensive and can be expanded to additional body organs, and different
modalities.
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1. Introduction
The combination of positron emission tomography (PET)
and computerized tomography (CT) scanners has become a
standard component of diagnosis and staging in oncology [23,
13]. An increased accumulation of Fluoro-D-glucose (FDG)
in PET relative to normal tissue is a useful marker for many
cancers and can help in detection and localization of malignant
lesions [13]. Additionally, PET/CT imaging is becoming an im-
portant evaluation tool for new drug therapies [25]. An exam-
ple of an axial slice taken from a CT scan and its corresponding
PET slice is shown in Figure 1. It can be seen that the PET
image resolution is lower than the CT image resolution show-
ing less anatomical details. However, there is a malignant liver
lesion that is less visible in the CT image and can be easily
detected in the PET image as a large dark blob.
Although PET imaging has many advantages and its use is
steadily increasing, it has a few disadvantages. PET/CT en-
tails added radiation exposure in comparison to CT-only scans.
Moreover, PET/CT is relatively expensive compared to CT.
Hence, it is still not offered in the large proportion of medi-
cal centers in the world. The clinical importance of PET in the
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management of cancer patients and on the other hand the dif-
ficulty in providing PET imaging as part of standard imaging,
raises a potential need for an alternative, less expensive, fast,
and easy to use PET-like imaging.
Figure 1: An axial CT slice (left) with its corresponding PET slice (right). Dark
regions in the PET image indicate high FDG uptake.
Several works had recently explored cross-modality synthe-
sis using deep learning methods [19, 10, 26]. In these works,
different deep learning based methods and architectures were
explored to learn an end-to-end nonlinear mapping from mag-
netic resonance images to CT images. For the case of unpaired
data, a CycleGAN model was used to synthesize brain CT im-
ages from brain MR by Wolterink et al. [24]. Chartsias et al.
[6] demonstrated a similar concept for synthesizing cardiac MR
images from CT images. In the case of PET/CT pairs, the PET
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study can be used to highlight malignant lesions and improve
the detection compared to the use of CT data alone. Bi et al. [5]
used a multi-channel generative adversarial network that syn-
thesizes PET images from CT images with manually annotated
lung tumors. Their model learns the integration from both CT
and a given annotated label, to synthesize the high uptake and
the anatomical background. They have demonstrated using the
synthesized PET images a comparable detection performance
to that achieved using the original PET data. We note that man-
ual labeling of the tumors is needed in this work.
In the current work our objective is to use information from
CT data to estimate PET-like images with an emphasis on ma-
lignant lesions in the liver. The suggested system is fully au-
tomated, with no manual labeling needed. Similar to the ra-
diologists, who have an easier time identifying malignant liver
lesions in a PET/CT scan (vs only a CT scan) we want to make
use of the estimated PET-like images to improve the detection
of malignant lesions using an automated lesion detection soft-
ware.
The proposed system is based on a fully convolutional net-
work (FCN) and a conditional GAN (cGAN). The contribu-
tions of this work include: 1) We present a novel method to
synthesize PET images from CT images, focused on malignant
lesions with no manually labeled data; 2) The synthesized PET
is shown to improve an existing automatic lesion detection soft-
ware; 3) Reconstruction measures are presented for comparison
between different methods.
This work is an extension to earlier work [4], in which we
used a pyramid based image blending step to combine the ad-
vantages of an FCN and a cGAN network. In the current work
we present a novel system architecture that obviates the need for
an image blending step, thus providing savings in time and re-
ducing the need for manually defining a threshold for the blend-
ing mask, while improving the system performance (as will be
demonstrated in section 3). In addition, the dataset was sub-
stantially extended.
To achieve the virtual PET we use advanced deep learning
techniques with both fully convolutional networks and condi-
tional adversarial networks as described in the following sub-
sections.
1.1. Fully Convolutional Networks
In recent years, deep learning has become a dominant re-
search topic in numerous fields. Specifically, Convolutional
Neural Networks (CNN) have been used for many challenges
in computer vision. CNN obtained outstanding performance on
different tasks, such as visual object recognition, image clas-
sification, hand-written character recognition and more. Deep
CNNs introduced by LeCun et al. [17], is a supervised learning
model formed by multi-layer neural networks. CNNs are fully
data-driven and can retrieve hierarchical features automatically
by building high-level features from low-level ones, thus ob-
viating the need to manually customize hand-crafted features.
Previous works have shown the benefit of using a fully con-
volutional architecture for liver lesion detection and segmen-
tation applications [2, 8]. FCNs can take input of arbitrary
size and produce correspondingly-sized output with efficient
Figure 2: Training a cGAN to predict PET images from CT images. The dis-
criminator, D, learns to classify between real and synthesized pairs. The gener-
ator, G, learns to fool the discriminator.
inference and learning. Unlike patch based methods, the loss
function using this architecture is computed over the entire im-
age. The network processes entire images instead of patches,
which removes the need to select representative patches, elimi-
nates redundant calculations where patches overlap, and there-
fore scales up more efficiently with image resolution. More-
over, there is a fusion of different scales by adding links that
combine the final prediction layer with lower layers with finer
strides.
1.2. Conditional Adversarial Networks
More recent works show the use of Generative Adversarial
Networks (GANs) for image to image translation [12]. GANs
are generative models that learn a mapping from random noise
vector z to output image y [9]. In contrast, conditional GANs
(cGANs) learn a mapping from observed image x and random
noise vector z, to y. The generator G is trained to produce out-
puts that cannot be distinguished from real images by an adver-
sarially trained discriminator, D, which is trained to detect real
vs fake images. Figure 2 shows a diagram of this procedure.
In this study we use FCN and cGAN to generate PET-like
images from CT volumes. The strengths of both methods are
used to create realistic looking virtual PET images. We focus
our attention to hepatic malignant lesions. The method is pre-
sented in Section 2. Experiments and results are described in
Section 3. The experiments include comparison of various al-
gorithmic solutions to the task along with an evaluation of the
benefit of our method to an existing automatic liver lesion de-
tection software. We conclude this paper with a discussion in
Section 4.
2. Methods
Our framework includes two main modules: a training mod-
ule which includes data preparation, and a testing module which
2
Figure 3: The proposed virtual PET system.
accepts CT images as input and predicts synthesized PET im-
ages. We use an FCN to generate initial PET-like images given
the input CT images. We next use a cGAN to improve and re-
fine the FCN output. Figure 3 shows a diagram of our general
framework. Each module will be described in depth in the fol-
lowing subsections.
2.1. Training Data Preparation
The training input for the FCN includes two image types: a
source CT image and a target PET image. A similar size is
needed for the two images and in most cases the PET resolu-
tion is much lower than the CT. Hence, the first step in prepar-
ing the data for training was to align the PET scans with the
CT scans using the given offset (provided for each scan) and
the voxel size (in mm) ratio between both scans. Let us de-
note T = (tx, ty, tz) as the given offset between the CT and
the PET scan, S ct = (hct,wct, dct) as the CT voxel size, and
S pet = (hpet,wpet, dpet) as the PET voxel size with h, w, d repre-
senting the size in each dimension. Note that larger voxel size
means lower resolution. Next, the following affine transforma-
tion with linear interpolation is used to align the PET scan to
the CT scan:
A =

hpet/hct 0 0 tx
0 wpet/wct 0 ty
0 0 dpet/dct tz
0 0 0 1

The standardized uptake value (SUV) is commonly used as a
relative measure of FDG uptake [11] as in equation 1:
S UV =
r
a′/w
(1)
where r is the radioactivity concentration [kBq/ml] measured
by the PET scanner within a region of interest (ROI), a′ is the
decay-corrected amount of injected radiolabeled FDG [kBq],
and w is the weight of the patient [g], which is used as a surro-
gate for a distribution volume of tracer.
CT and PET studies include a large value range. To assist
the network to learn the translation between these modalities,
we found experimentally that some constraints were helpful:
we used contrast adjustment, by clipping extreme values and
scaling, to adjust the PET images into the SUV range of 0 to
20. This range includes most of the interesting SUV values of
malignant lesions. Similarly, CT image values were adjusted to
be within -160 HU to 240 HU (Hounsfield Units); the standard
HU windowing used by the radiologists when evaluating the
liver parenchyma. Let us denote the minimum value of interest
in a given scan I as Imin and the maximum value of interest as
Imax. These extreme values are clipped as follows:
I˜ =

Imin, if I < Imin
Imax, if I > Imax
I, otherwise
(2)
where I˜ is the result of the clipping operation. Additionally,
each scan values were linearly adjusted to [0, 1] as in:
I f inal = (I˜ − Imin)/(Imax − Imin) (3)
2.2. Fully Convolutional Network Architecture
In the following we describe the FCN used for both training
and testing as in Figure 3a and 3b. The FCN network archi-
tecture uses the VGG 16- layer net [22]. We convert all fully
connected layers to convolutions and remove the classification
layer. We append a 1x1 convolution with channel dimension
to generate the PET-like images. Upsampling is performed in-
network for end-to-end learning by backpropagation from the
pixelwise L2 loss. The FCN-4s net was used as our network,
which learned to combine coarse, high layer information with
fine, low layer information as described in [21] with an addi-
tional skip connection by linking the Pool2 layer in a similar
way to the linking of the Pool3 and Pool4 layers in Figure 4.
2.3. cGAN Architecture
The output from the FCN was found experimentally to have a
good response in regions with high SUV but to be less accurate
and blurry in regions with low contrast. Hence, cGAN was used
to refine the FCN’s output. The input to the cGAN included
two channels, one with the CT image and the second with the
corresponding FCN output (simple concatenation). The train-
ing concept follows the same trend of the training process of the
FCN optimizing the network’s generator based on the pixelwise
L2 loss as well as the cross entropy classification error for the
discriminator, as will be further elaborated in section 2.4. We
adapt a similar cGAN architecture as in [12] with a few modi-
fications. In the original cGAN the objective can be expressed
as:
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Figure 4: FCN-4s architecture. Each convolution layer is illustrated by a
straight line with the receptive field size and number of channels denoted above.
The ReLU activation function and drop-out are not shown for brevity.
LcGAN(G,D) =Ect,pet[log D(ct, pet)]+
Ect,z[log(1 − D(ct,G(ct, z))] (4)
where G tries to minimize this objective against an adversar-
ial D that tries to maximize it, ct is the CT input slice, pet is
the corresponding PET slice, and z is a Gaussian random noise
variable, in the range of [-0.005, 0.005], that was added to the
CT input slice in each epoch. In our objective we embed the
FCN’s output ( f cn) as in:
LModi f ied−cGAN(G,D) =E f cn,ct,pet[log D( f cn, ct, pet)]+
E f cn,ct,z[log(1 − D( f cn, ct,G( f cn, ct, z))]
(5)
We tried both L1 and L2 distance measures for the generator
G. No noticeable difference was observed using the different
distance measures and we chose to use the L2 in our experi-
ments. The final optimization process:
G∗ =arg minGmaxDLModi f ied−cGAN(G,D)+
λE f cn,ct,z,pet‖pet −G( f cn, ct, z)‖2 (6)
where G∗ is the optimal setting and λ balances the contribu-
tion of the two terms.
Table 1 and Table 2 show the different components of the
network for the ”U-Net” [20] based generator (encoder and de-
coder) and the discriminator respectively.
2.4. Loss Weights
Malignant lesions are usually observed with high SUV values
(> 2.5) in PET scans [16]. We note that most of the SUV values
in PET scans are low and only a minority include high SUVs.
Table 1: The ”U-Net” based generator used in the proposed cGAN architecture.
U-Net encoder U-Net decoder
Layer Details Size Layer Details Size
input
CT image;
FCN’s output
512x512
x2 upsampling1
2x2 upsample of conv5 2
concatenate with conv4 2
64x64
x768
conv1 1
3x3x32; dilaton rate 3;
LeakyReLU
512x512
x32 conv6 1
3x3x256;
LeakyReLU
64x64
x256
conv1 2
3x3x32; dilaton rate 3;
LeakyReLU
512x512
x32 conv6 2
3x3x256;
LeakyReLU
64x64
x256
pool1 2x2 max pool; stride 2
256x256
x32 upsampling2
2x2 upsample of conv6 2
concatenate with conv3 2
128x128
x384
conv2 1
3x3x64; dilaton rate 2;
LeakyReLU
256x256
x64 conv7 1
3x3x128;
LeakyReLU
128x128
x128
conv2 2
3x3x64; dilaton rate 2;
LeakyReLU
256x256
x64 conv7 2
3x3x128;
LeakyReLU
128x128
x128
pool2 2x2 max pool; stride 2
128x128
x64 upsampling3
2x2 upsample of conv7 2
concatenate with conv2 2
256x256
x192
conv3 1
3x3x128;
LeakyReLU
128x128
x128 conv8 1
3x3x64; dilaton rate 2;
LeakyReLU
256x256
x64
conv3 2
3x3x128;
LeakyReLU
128x128
x128 conv8 2
3x3x64; dilaton rate 2;
LeakyReLU
256x256
x64
pool3 2x2 max pool; stride 2
64x64
x128 upsampling4
2x2 upsample of conv8 2
concatenate with conv1 2
512x512
x96
conv4 1
3x3x256;
LeakyReLU
64x64
x256 conv9 1
3x3x32; dilaton rate 3;
LeakyReLU
512x512
x32
conv4 2
3x3x256;
LeakyReLU
64x64
x256 conv9 2
3x3x32; dilaton rate 3;
LeakyReLU
512x512
x32
pool4 2x2 max pool; stride 2
32x32
x256 conv10 1x1x1
512x512
x1
conv5 1
3x3x512;
LeakyReLU
32x32
x512
conv5 2
3x3x512;
LeakyReLU
32x32
x512
Table 2: The discriminator used in the proposed cGAN architecture.
Discriminator
Layer Details Size
input
Includes: real/fake PET image;
CT image;FCN’s output 512x512x3
conv1 3x3x32; stride 2; LeakyReLU 256x256x32
conv2 3x3x64; stride 2; LeakyReLU 128x128x64
conv3 3x3x128; stride 2; LeakyReLU 64x64x128
conv4 3x3x256; stride 1; LeakyReLU 64x64x256
dense 2 classes (fake/real);softmax 2
Hence, we used the SUV value in each pixel as a weight for
the pixel-wise loss function as in equation (7), where N is the
number of samples. By this we allow the network to pay more
attention to high SUVs even though most pixels include lower
values.
L =
1
N
N∑
i=1
IPET (i)(S ynPET (i) − IPET (i))2 (7)
While this approach helped the FCN to learn the malignant tu-
mor appearance and provide a better response in the synthesized
PET images, it did not help when training the cGAN. Hence,
we modified the loss function by computing the weighted av-
erage reconstruction loss (equation 7) for high SUVs (> 2.5)
and for low SUVs (≤ 2.5) as in equation (8). This way the
cGAN training was able to achieve better response in regions
with high SUV while not substantially reducing the quality of
reconstruction in other regions.
LcGAN = LlowS UV + LhighS UV (8)
3. Experiments and Results
To evaluate the performance of the system, we conducted
several sets of experiments. A development set was used for
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training and validation. Final results are presented for an in-
dependent testing set. We demonstrate the applicativity of the
system to augment performance of a liver lesion detection sys-
tem.
3.1. Dataset
An institutional review board (IRB) approval was granted
for this retrospective study and informed consent was waived
by the IRB committee. The data used in this work includes
PET/CT scans (pairs of contrast enhanced portal phase CT
scans with their corresponding PET scans) from the Sheba
Medical Center, obtained from 2014 to 2015. The dataset con-
tains 60 CT (with 0.97 mm pixel spacing and 4 mm slice thick-
ness) and PET (with 3 mm pixel spacing and 4 mm slice thick-
ness) pairs (from 60 different patients) which we constrained to
slices in the region of the liver for our study. Not all PET/CT
scans in our dataset included liver lesions. The data was col-
lected in two phases. In the first phase the collected data in-
cluded PET/CT scans that were used for the development and
validation of the explored methods. In the second phase new
data was collected for testing with no additional modifications
of the algorithms. The training set included 23 PET/CT pairs (6
with malignant liver lesions) and the testing was performed on
37 pairs (9 with malignant liver lesions).
3.2. Experimental Setting
The networks were implemented and trained using Keras
framework [7] on a PC with a single NVIDIA 1080 Ti GPU.
The following hyper-parameters were used for all networks:
learning rate of 0.00001 with a batch size of 4. Adam optimizer
[15] was used with β = 0.5. For the cGAN, we used λ = 20
in the optimization process presented in equation 6. To assist
the network model to be more robust to variability in location
and scaling, online data transformations were performed with
uniform sampling of scale [-0.9,1.1] and translations [-25,25]
in each epoch. We randomly chose 20% of the training images
for validation which were used to optimize the training process.
3.3. Reconstruction Evaluation
To quantitatively evaluate our method performance in means
of reconstruction we used the mean absolute error:
MAE =
1
N
N∑
i=1
|S ynPET (i) − IPET (i)| (9)
where i iterates over aligned voxels in the real and synthesized
PET images.
In addition, the peak-signal-to-noise-ratio (PSNR) as in [19,
24] was used:
PS NR = 10 log10
202
MS E
(10)
where MS E is the mean-squared error, i.e. 1N
∑N
i=1(S ynPET (i)−
IPET )2.
Our goal is to get very good reconstruction in the lesion ar-
eas, while keeping high reconstruction quality within the entire
scan. High SUV values within a PET scan often serve as an
indicator for the malignant lesions. We therefore measure the
reconstructive error for the high SUV values (larger than 2.5)
and the low SUV values, as two separate sets. The average of
these measures is computed as the final score. Table 3 shows
quantitative comparison across several possible reconstruction
schemes. Detailed description of the rows of the table is pro-
vided next:
FCN. In the first set of experiments we tested four different
fully convolutional networks: 1) The U-net based model as in
Table 1; 2) The FCN-4s as in Figure 4; 3) The FCN-8s that
does not make use of the pool2 layer in the upsampling path as
in [21]; 4) The FCN-2s that additionally uses the pool1 layer
for the upsampling path. Table 3 shows that the U-Net results
in larger reconstruction error for high SUV regions compared
to the other tested FCNs. The FCN-8s, FCN-4s, and FCN-2s
achieved similar results. In previous works the FCN-4s showed
promising performance in the liver lesion detection task includ-
ing small lesions [2, 3]. Hence we select to use the FCN-4s in
the proposed solution. We used the loss as in equation 7 for
training.
cGAN. The second component of the proposed method is
the cGAN. We compared two cGAN architecture variations:
1) Using the U-Net based generator as in Table 1 (“GAN-U-
Net gen.”); 2) Using the FCN-4s as a generator ( “GAN-FCN-
4s gen.”). Table 3 indicates better reconstruction performance
in the low SUV regions when using the “GAN-U-Net gen.”.
We therefore use it as a refinement step to the the FCN out-
put that had better reconstruction performance in the high SUV
regions. In addition, the “GAN-U-Net gen.” had faster conver-
gence compared to the “GAN-FCN-4s gen.”. We used the loss
as in equation 8 for training.
Combined. Our proposed method combines the FCN-4s and
the cGAN. We test it next using three different loss functions:
loss presented in equation 8, loss presented in equation 7, and
the standard L2 loss. In addition, we compared the results to
pyramid-based image blending [4]. From Table 3 we see that
the proposed method showed superiority over the other meth-
ods with an average MAE of 0.72 and 0.79, and PSNR of 30.22
and 30.4 using the loss as in equation 8 and equation 7, respec-
tively. When using the loss as in equation 7 instead of equation
8 our method achieved a better average PSNR, however, we
preferred to use the latter since it achieved better reconstruction
measurements for the high SUVs.
Qualitative results are shown in Figure 5. It compares the
method’s virtual PET images with the original PET study im-
ages. The virtual PET provided a very similar response to the
real PET in the presented cases. The left column includes one
malignant lesion, the second column includes three liver metas-
tases (malignant lesions), and the right column includes two
cysts (benign lesions). In Figure 6 we use the same sample
cases as in Figure 5 and have compared our proposed method
to the image blending based method [4]. In the left column
we can see that the malignant lesion has been recognized using
both methods as a dark blob which seems slightly darker and
larger using our method. In the second column the three ma-
lignant lesions were recognized using both methods, however,
the image blending based method included several blobs that
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Table 3: Average reconstruction performance for low and high SUV regions using different methods. In bold - the highest scores in each column.
Method High SUV Low SUV Average ScoreMAE PSNR MAE PSNR MAE PSNR
C
om
bi
ne
d *FCN-4s-cGAN Eq. (8) 1.33 ± 0.65 22.40 ± 2.92 0.11 ± 0.04 38.04 ± 1.92 0.72 ± 0.35 30.22 ± 2.42
*FCN-4s-cGAN Eq. (7) 1.48 ± 0.66 21.70 ± 2.95 0.09 ± 0.05 39.1 ± 1.95 0.79 ± 0.36 30.4 ± 2.45
FCN-4s-cGAN L2 1.55 ± 0.66 21.10 ± 2.94 0.10 ± 0.04 39.03 ± 1.94 0.83 ± 0.35 30.07 ± 2.44
Blending 1.50 ± 0.63 21.40 ± 2.94 0.10 ± 0.04 39.00 ± 2.03 0.80 ± 0.34 30.20 ± 2.49
cG
A
N cGAN-U-Net gen. 1.70 ± 0.61 20.62 ± 2.92 0.10 ± 0.04 39.06 ± 1.90 0.90 ± 0.33 29.84 ± 2.41
cGAN-FCN-4s gen. 1.52 ± 0.63 21.10 ± 3.10 0.12 ± 0.04 37.60 ± 1.95 0.82 ± 0.34 29.35 ± 2.53
FC
N
FCN-4s 1.33 ± 0.59 22.50 ± 2.93 0.16 ± 0.05 37.60 ± 1.99 0.74 ± 0.32 30.05 ± 2.46
FCN-8s 1.33 ± 0.57 22.45 ± 2.92 0.15 ± 0.05 37.63 ± 1.99 0.74 ± 0.31 30.04 ± 2.46
FCN-2s 1.37 ± 0.62 22.42 ± 3.02 0.14 ± 0.05 37.70 ± 2.02 0.76 ± 0.34 30.06 ± 2.52
U-Net 1.52 ± 0.67 21.57 ± 3.1 0.12 ± 0.04 38.56 ± 1.74 0.82 ± 0.36 30.07 ± 2.42
*Proposed method
Figure 5: Sample results of the predicted PET using our method compared to
the real PET with the corresponding CT images.
are false-positives marked in red. In the right column there are
two cysts (benign lesions), and both methods did not have high
response as expected, however, our proposed method seems to
have a better result for the surrounding tissues such as the left
kidney marked in green.
3.4. Liver Lesion Detection using the Virtual-PET
In the following experiment, we use the synthesized (Virtual)
PET images as an additional false-positive reduction layer for
an existing lesion detection software. Since high SUV values
can be indicative of malignant lesions, thresholding the PET
using a high SUV threshold (th = 2.5) can reduce non-relevant
regions for lesion detection. We use a particular lesion detection
system, that was developed in our group [3], which combines
global context via an FCN, along with local patch level analysis
using superpixel sparse based classification. This framework is
made up of two main modules. The first module is an FCN hav-
ing three slices are as input: the target slice in the center and two
adjacent slices above and below. Using an FCN - based analy-
sis, this module outputs a lesion probability map. Based on the
high-probability candidate lesion regions from the first module,
Figure 6: Sample results of the predicted PET using our method compared to
the image blending based method [4]. In green - correctly synthesized high
SUV regions; In red - false synthesized high SUV regions.
the second module follows with localized patch level analysis
using superpixel sparse based classification. This module’s ob-
jective is to classify each localized superpixel as a lesion or
not. Thus it provides a fine-tuning step, with the objective of
increasing sensitivity to lesions while removing false positives
(FPs).
We suggest the following scheme for improving the lesion
detection software: Given a CT scan, the detection software
outputs lesion candidates as a binary mask which may include
false detections. By thresholding the synthesized PET scan and
finding the intersection of both the detection software’s candi-
dates mask and the PET thresholding result some of the false
detections can be removed. Figure 7 illustrates this process.
This is a rather naı¨ve approach that shows the clinical relevance
of using the virtual PET to improve existing software.
An additional test set of 14 CT scans including 55 lesions
was used for the following experiments. Two evaluation mea-
surements were computed, the true positive rate (TPR) and false
positive rate (FPR) for each case as follows:
• T PR- Number of correctly detected lesions divided by the
total number of lesions.
• FPR- Number of false positives per scan.
Table 4 shows the performance with and without the pro-
posed false-positive reduction layer (note that the results were
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Figure 7: Combining our proposed method to synthesize PET with a lesion
detection software: The output of the detection software includes true positives
(in green) along with false positives (in red). Thresholding over the synthesized
PET image to extract high-response regions (in blue) can help reduce the false
positives by intersecting the detection mask with the thresholding mask.
Table 4: Detection measurements with and without SUV thresholding on the
synthesized PET. In bold - the results obtained using the proposed method.
Method TPR[%] Average FPR
Detection soft. 94.6 2.9 ± 2.1
Detection soft+ proposed 94.6 2.1 ± 1.7
Detection soft+ blending 90.9 2.2 ± 1.7
Detection soft+ FCN-4s 90.9 2.2 ± 1.7
constrained to the manually annotated liver). Using our method
the average FPR decreased from 2.9 to 2.1 (improvement of
28% with P-value<0.05) with a similar TPR.
Figure 8 shows examples of cases with false positives that
were removed (in red) by combining the proposed method with
the existing detection software.
One key parameter of the detection system is the probabil-
ity threshold, th, which defines the set of candidate regions ex-
tracted from the FCN probability maps. We compare the free-
response receiver operating characteristic (FROC) presented in
[3] with the FROC achieved using the combination of the syn-
thesized PET with the current system (Figure 9). It can be seen
that our system was able to reduce the amount of false positives
in each tested th while preserving the TPR. Unlike the classic
FROC curve where the TPR increases for decreasing th, here
there was a moderate decrease for th below 0.95. The TPR can
decrease when two candidates merge into one candidate even
though there are two lesions. Note that We used th = 0.95 in
our experiments (table 4 and figure 8) as in the original system.
As a final experiment, we tested a fully automatic frame-
work with an automatic liver segmentation scheme, as in [3].
Thus, we use an automatic liver segmentation instead of the
manually circumscribed liver. Using our method the average
FPR decreased from 3.0 to 2.3 (improvement of 23% with P-
Figure 8: Sample results using the existing detection software. In green - cor-
rectly detected lesions. In red - false positives that were removed by combining
the proposed method.
Figure 9: FROC curve of lesion detection using FCN with sparsity based FP
reduction (solid black line) and with the addition of synthesized PET FP reduc-
tion (dashed blue line).
value<0.05) with a slight decrease of the TPR from 90.9% to
89.1% (not significant).
4. Discussion
A novel system for PET synthesis using only CT scans has
been presented. The presented system includes an FCN model
and a cGAN model that refines the synthesized output extracted
from the FCN. This framework provides a realistic PET estima-
tion with special attention to malignant lesions using a custom
loss function for each model.
Table 3 shows the reconstruction performance in terms of
MAE and PSNR for high SUV regions, low SUV regions, and
an average of both which is an estimate of the balance we want
to have between these regions. The high SUV regions are im-
portant since they usually signify malignant lesions inside the
liver, but it is important to reconstruct the low SUV regions as
well, since we want to have a good contrast between malig-
nant and non-malignant tissues. The FCN-4s achieved the best
PSNR and MAE for the high SUV regions with our proposed
method achieving very close performance measures. However,
for the low SUV regions, the FCN-4s got inferior PSNR and
MAE, while the cGAN and the image blending got the best re-
sults. Using the average scores our proposed method seems to
have the best balance between the high and low SUV regions.
In an additional experiment we wanted to see if the proposed
method can be used to improve an existing automatic liver le-
sion detection software [3]. Our system was easily integrated
into the lesion detection software. Using a pathological SUV
threshold of 2.5 we achieved a decrease in false-positive from
an average of 2.9 per case to 2.1 (28% improvement). This ex-
periment shows the benefit of using the proposed system to im-
prove a given liver lesion analysis software. Since this method
was trained on a dataset that was not seen by the existing detec-
tion software it improved its results. However, no manual la-
beling was conducted in this experiment since our method uses
only PET/CT pairs for training.
The current work includes several limitations, which we dis-
cuss next. The experiments conducted in this study focused
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on the liver region. The liver is a common site for metastases
in oncological patients, hence, more examples of malignan-
cies can be extracted and can help the training process. More
work should be done to make use of the proposed framework
for other malignancies within different regions in the CT scan,
preferably with no manually annotated labels. Adaptation of
this method to other types of malignant tumors may require to
re-train it per-organ since different malignant tumors have dif-
ferent appearances in CT images (e.g. lung cancer vs. liver
cancer). We used online data augmentation including scaling
and translation, and random noise addition in the training pro-
cess. Additional data augmentation techniques such as random
distortions and deformations or image rotations can be used
to further improve the system performance and robustness but
were not found necessary in our experiments. An additional
point that could be explored is the combination of the FCN
output with the training of the cGAN. We have proposed to
concatenate the FCN output to the CT image as input to the
cGAN and compared it to a pyramid based image blending ap-
proach. However, different merging approaches should be ex-
plored within the cGAN generator. For example, using the FCN
output as an input to separate group of layers in the network and
merge with the CT image deeper in the network model. One of
the parameters that we use in our system is the SUV cut-off
value. Although our system shows adequate results using 2.5
as the cut-off value, tweaking it may perhaps further optimize
our method.
One possible application could be to use the virtual PET to
improve lesion segmentation. However, the PET images are
quite blurry and so is the virtual PET, making it hard to assess
the segmentation process. Hence, we believe that detection ap-
proaches are more relevant for this method.
We used a rather naı¨ve approach by thresholding the virtual
PET to reduce the amount of false-positives per case in an ex-
isting lesion detection software. However, the proposed system
can be easily integrated into the training process of different
networks for different tasks such as detection (as shown here)
and classification.
To conclude, our proposed framework with the FCN-cGAN
combination and the custom loss function has shown promising
results in terms of reconstruction measures as well as detec-
tion measures by integrating it with an existing lesion detection
software. A major strength of this paper is that no manual la-
beling was used to train the system. As we well know, the task
of manually labeling and annotating medical data is hard, and
contributes to the usually small data sets that are used in todays
medical imaging research. Each year millions of PET/CT stud-
ies are conducted worldwide, and utilizing the current method,
the CT and PET pairing can be used as free labeled and an-
notated data, with potential for big data, approaching millions
of studies. Future work entails obtaining a larger dataset with
vast experiments using the entire CT and not just the liver re-
gion as well as integrating it into the training process of deep
learning based detection and classification networks. The pre-
sented system can be used for many applications in which PET
examination is needed such as evaluation of drug therapies and
detection of malignant lesions.
Acknowledgment
This research was supported by the Israel Science Founda-
tion (grant No. 1918/16).
Avi Ben-Cohen’s scholarship was funded by the Buchmann
Scholarships Fund.
Disclosure of conflict of interest
The authors have no relevant conflicts of interest to disclose.
References
[1] Adelson, E. H., Anderson, C. H., Bergen, J. R., Burt, P. J., and Ogden, J.
M.,1984. Pyramid methods in image processing. RCA engineer, 29(6), pp.
33-41.
[2] Ben-Cohen, A., Diamant, I., Klang, E., Amitai, M., and Greenspan,
H., 2016. Fully Convolutional Network for Liver Segmentation and Le-
sions Detection. In International Workshop on Large-Scale Annotation of
Biomedical Data and Expert Label Synthesis. Springer International Pub-
lishing, pp. 77-85.
[3] Ben-Cohen, A., Klang, E., Kerpel, A., Konen, E., Amitai, M. M., and
Greenspan, H., 2017. Fully convolutional network and sparsity-based dic-
tionary learning for liver lesion detection in CT examinations. Neurocom-
puting.
[4] Ben-Cohen, A., Klang, E., Raskin, S. P., Amitai, M. M., and Greenspan,
H.,2017. Virtual PET Images from CT Data Using Deep Convolutional
Networks: Initial Results. In International Workshop on Simulation and
Synthesis in Medical Imaging. Springer, Cham, pp. 49-57.
[5] Bi, L., Kim, J., Kumar, A., Feng, D., and Fulham, M., 2017. Synthesis of
Positron Emission Tomography (PET) Images via Multi-channel Genera-
tive Adversarial Networks (GANs). In Molecular Imaging, Reconstruction
and Analysis of Moving Body Organs, and Stroke Imaging and Treatment.
Springer, Cham, pp. 43-51.
[6] Chartsias, A., Joyce, T., Dharmakumar, R., and Tsaftaris, S. A., 2017. Ad-
versarial Image Synthesis for Unpaired Multi-modal Cardiac Data. In In-
ternational Workshop on Simulation and Synthesis in Medical Imaging.
Springer, Cham, pp. 3-13.
[7] Chollet, Franc¸ois et al.: Keras. https://github.com/keras-team/
keras. GitHub, (2015).
[8] Christ, P. F., Ettlinger, F., Grn, F., Elshaera, M. E. A., Lipkova, J., Schlecht,
S., ... and Rempfler, M., 2017. Automatic Liver and Tumor Segmentation
of CT and MRI Volumes using Cascaded Fully Convolutional Neural Net-
works. arXiv preprint arXiv:1702.05970.
[9] Goodfellow, I., Pouget-Abadie, J., Mirza, M., Xu, B., Warde-Farley, D.,
Ozair, S., and Bengio, Y.,2014. Generative adversarial nets. In Advances
in neural information processing systems, pp. 2672-2680.
[10] Han, X.,2017. MR based synthetic CT generation using a deep convolu-
tional neural network method. Medical Physics, 44(4), pp. 1408-1419.
[11] Higashi, K., Clavo, A. C., and Wahl, R. L.,1993. Does FDG Uptake Mea-
sure the Proliferative Activity of Human Cancer Cells? In Vitro Compar-
ison with DNA Flow Cytometry and Tritiated Thymidine Uptake. Journal
of Nuclear Medicine, 34, 414-414.
[12] Isola, P., Zhu, J. Y., Zhou, T., and Efros, A. A.,2016. Image-to-
image translation with conditional adversarial networks. arXiv preprint
arXiv:1611.07004.
[13] Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A.,
Cheng, E. Y., and Shankar, L., 2005. Progress and promise of FDG-PET
imaging for cancer patient management and oncologic drug development.
Clinical Cancer Research, 11(8), 2785-2808.
[14] Kinehan, P. E., and Fletcher, J. W., 2010. PET/CT standardized uptake
values (SUVs) in clinical practice and assessing response to therapy. Semin
Ultrasound CT MR, 31(6), 496-505.
[15] Kingma, D. P., and Ba, J., 2014. Adam: A method for stochastic opti-
mization. arXiv preprint arXiv:1412.6980.
[16] Kostakoglu, L., Agress Jr, H., and Goldsmith, S. J., 2003. Clinical role of
FDG PET in evaluation of cancer patients. Radiographics, 23(2), 315-340.
[17] LeCun, Y., Bottou, L., Bengio, Y., and Haffner, P.,1998. Gradient-
based learning applied to document recognition. Proceedings of the IEEE,
86(11), 2278-2324.
8
[18] Metz, C. E., 2006. Receiver operating characteristic analysis: a tool for
the quantitative evaluation of observer performance and imaging systems.
Journal of the American College of Radiology, 3(6), 413-422.
[19] Nie, D., Cao, X., Gao, Y., Wang, L., and Shen, D., 2016. Estimating
CT image from MRI data using 3D fully convolutional networks. In In-
ternational Workshop on Large-Scale Annotation of Biomedical Data and
Expert Label Synthesis. Springer International Publishing, pp. 170-178.
[20] Ronneberger, O., Fischer, P., and Brox, T.,2015. U-net: Convolutional
networks for biomedical image segmentation. In International Confer-
ence on Medical Image Computing and Computer-Assisted Intervention,
Springer International Publishing, pp. 234-241.
[21] Shelhamer, E., Long, J., and Darrell, T., 2016. Fully convolutional net-
works for semantic segmentation. IEEE transactions on pattern analysis
and machine intelligence.
[22] Simonyan, K., and Zisserman, A., 2014. Very deep convolutional net-
works for large-scale image recognition. arXiv preprint arXiv:1409.1556.
[23] Weber, W. A., Grosu, A. L., and Czernin, J., 2008. Technology Insight:
advances in molecular imaging and an appraisal of PET/CT scanning. Na-
ture Clinical Practice Oncology, 5(3), 160-170.
[24] Wolterink, J. M., Dinkla, A. M., Savenije, M. H., Seevinck, P. R., van
den Berg, C. A., and IÅgum, I., 2017. Deep MR to CT synthesis using
unpaired data. In International Workshop on Simulation and Synthesis in
Medical Imaging. Springer, Cham, pp. 14-23.
[25] Weber, W. A., 2009. Assessing tumor response to therapy. Journal of nu-
clear medicine, 50(Suppl 1), 1S-10S.
[26] Xiang, L., Wang, Q., Nie, D., Qiao, Y., and Shen, D., 2017. Deep Em-
bedding Convolutional Neural Network for Synthesizing CT Image from
T1-Weighted MR Image. arXiv preprint arXiv:1709.02073.
9
